106 related articles for article (PubMed ID: 8813653)
1. Pharmacokinetics of human recombinant tissue-type plasminogen activator, administered intra-abdominally, in a rat peritonitis model.
van Goor H; Bom VJ; van der Meer J; Sluiter WJ; Geerards S; van der Schaaf W; de Graaf JS; Bleichrodt RP
Eur Surg Res; 1996; 28(4):287-94. PubMed ID: 8813653
[TBL] [Abstract][Full Text] [Related]
2. Effects of intra-abdominal administration of recombinant tissue plasminogen activator on coagulation, fibrinolysis and inflammatory responses in experimental polymicrobial peritonitis.
van Veen SQ; Meijers JC; Levi M; van Gulik TM; Boermeester MA
Shock; 2007 May; 27(5):534-41. PubMed ID: 17438459
[TBL] [Abstract][Full Text] [Related]
3. Fibrinolytic activity in the abdominal cavity of rats with faecal peritonitis.
van Goor H; de Graaf JS; Grond J; Sluiter WJ; van der Meer J; Bom VJ; Bleichrodt RP
Br J Surg; 1994 Jul; 81(7):1046-9. PubMed ID: 7922060
[TBL] [Abstract][Full Text] [Related]
4. Tissue-type plasminogen activator prevents formation of intra-abdominal abscesses after surgical treatment of secondary peritonitis in a rat model.
Buyne OR; Bleichrodt RP; van Goor H; Verweij PE; Hendriks T
Int J Colorectal Dis; 2007 Jul; 22(7):819-25. PubMed ID: 17089129
[TBL] [Abstract][Full Text] [Related]
5. Gentamycin reduces bacteremia and mortality rates associated with the treatment of experimental peritonitis with recombinant tissue plasminogen activator.
van Goor H; de Graaf JS; Kooi K; Bleichrodt RP
J Am Coll Surg; 1995 Jul; 181(1):38-42. PubMed ID: 7599769
[TBL] [Abstract][Full Text] [Related]
6. Short-term effect of surgical trauma on rat peritoneal fibrinolytic activity and its role in adhesion formation.
Hellebrekers BW; Trimbos-Kemper GC; Bakkum EA; Trimbos JB; Declerck PJ; Kooistra T; Emeis JJ
Thromb Haemost; 2000 Nov; 84(5):876-81. PubMed ID: 11127871
[TBL] [Abstract][Full Text] [Related]
7. Statins (HMG-CoA reductase inhibitors) decrease postoperative adhesions by increasing peritoneal fibrinolytic activity.
Aarons CB; Cohen PA; Gower A; Reed KL; Leeman SE; Stucchi AF; Becker JM
Ann Surg; 2007 Feb; 245(2):176-84. PubMed ID: 17245169
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor 2 reduces peritoneal fibrinolytic activity in inflammation.
Whawell SA; Vipond MN; Scott-Coombes DM; Thompson JN
Br J Surg; 1993 Jan; 80(1):107-9. PubMed ID: 8428265
[TBL] [Abstract][Full Text] [Related]
9. Prevention of intraperitoneal adhesions and abscesses by polysaccharides isolated from Phellinus spp in a rat peritonitis model.
Bae JS; Ahn SJ; Yim H; Jang KH; Jin HK
Ann Surg; 2005 Mar; 241(3):534-40. PubMed ID: 15729079
[TBL] [Abstract][Full Text] [Related]
10. Tissue-type plasminogen activator prevents abscess formation but does not affect healing of bowel anastomoses and laparotomy wounds in rats with secondary peritonitis.
Buyne OR; Bleichrodt RP; De Man BM; Lomme RM; Verweij PE; van Goor H; Hendriks T
Surgery; 2009 Nov; 146(5):939-46. PubMed ID: 19744456
[TBL] [Abstract][Full Text] [Related]
11. Both tissue-type plasminogen activator and urokinase prevent intraabdominal abscess formation after surgical treatment of peritonitis in the rat.
Buyne OR; van Goor H; Bleichrodt RP; Verweij PE; Hendriks T
Surgery; 2008 Jul; 144(1):66-73. PubMed ID: 18571586
[TBL] [Abstract][Full Text] [Related]
12. Time course of peritoneal tissue plasminogen activator after experimental colonic surgery: effect of hyaluronan-based antiadhesive agents and bacterial peritonitis.
Reijnen MM; Holmdahl L; Kooistra T; Falk P; Hendriks T; van Goor H
Br J Surg; 2002 Jan; 89(1):103-9. PubMed ID: 11851673
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of normal saline and taurolidine on intra-abdominal adhesion formation and peritoneal fibrinolysis.
Tarhan OR; Barut I; Sezik M
J Surg Res; 2008 Jan; 144(1):151-7. PubMed ID: 17981298
[TBL] [Abstract][Full Text] [Related]
14. Effect of recombinant tissue plasminogen activator on intra-abdominal abscess formation in rats with generalized peritonitis.
van Goor H; de Graaf JS; Kooi K; Sluiter WJ; Bom VJ; van der Meer J; Bleichrodt RP
J Am Coll Surg; 1994 Oct; 179(4):407-11. PubMed ID: 7921389
[TBL] [Abstract][Full Text] [Related]
15. Fibrinolytic responses of human peritoneal fluid in laparoscopic cholecystectomy: a prospective clinical study.
Tarhan OR; Barut I; Akdeniz Y; Sutcu R; Cerci C; Bulbul M
Surg Endosc; 2008 Apr; 22(4):1008-13. PubMed ID: 17763904
[TBL] [Abstract][Full Text] [Related]
16. Peritoneal fibrinolytic activity in peritonitis.
Ince A; Eroglu A; Tarhan O; Bülbül M
Am J Surg; 2002 Jan; 183(1):67-9. PubMed ID: 11869706
[TBL] [Abstract][Full Text] [Related]
17. Timing and dose of tissue plasminogen activator to prevent abscess formation after surgical treatment of secondary peritonitis in the rat.
Buyne OR; van Goor H; Verweij PE; Bleichrodt RP; Hendriks T
Surg Innov; 2009 Dec; 16(4):299-305. PubMed ID: 20031941
[TBL] [Abstract][Full Text] [Related]
18. Substance P is an early mediator of peritoneal fibrinolytic pathway genes and promotes intra-abdominal adhesion formation.
Esposito AJ; Heydrick SJ; Cassidy MR; Gallant J; Stucchi AF; Becker JM
J Surg Res; 2013 May; 181(1):25-31. PubMed ID: 22765994
[TBL] [Abstract][Full Text] [Related]
19. Tissue-type plasminogen activator (tPA) and its inhibitor (PAI-1) in patients treated with continuous ambulatory peritoneal dialysis.
Opatrný K; Opatrná S; Vít L; Opatrný K
Am J Nephrol; 1998; 18(3):186-92. PubMed ID: 9627033
[TBL] [Abstract][Full Text] [Related]
20. Pentoxifylline, a methyl xanthine derivative, reduces peritoneal adhesions and increases peritoneal fibrinolysis in rats.
Tarhan OR; Barut I; Sutcu R; Akdeniz Y; Akturk O
Tohoku J Exp Med; 2006 Jul; 209(3):249-55. PubMed ID: 16778372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
